Antibiotics optimization and 
the burden of carrying  
a penicillin allergy label
Most medicines remain effective for prolonged 
periods, even when used by many people. 
Antibiotics are a critical exception: Antimicrobial 
resistance (AMR) diminishes their effectiveness over 
time. 
Since the discovery of penicillin in 1928, medicine 
has made tremendous advances, but very few 
new antibiotics have been developed. The World 
Health Organization (WHO) warned in 2017 that new 
antibiotic development is insufficient to keep pace 
with rising resistance.
To guide safe and effective antibiotic use, the WHO 
developed the AWaRe antibiotic categorization. 
In this system, beta-lactam antibiotics – including 
penicillins – are identified as “first-choice” options 
because they offer the best balance of effectiveness, 
safety, and minimal resistance risk.1
Unfortunately, the impact of these antibiotics has 
been undermined by inaccurate allergy labels 
to penicillin and related drugs such as amoxicillin and 
amoxicillin-clavulanic acid. These erroneous labels 
often prevent optimal antibiotic use and contribute to 
the growing resistance problem.2
In a recent study conducted at Tufts University and 
the Massachusetts Department of Public Health, 
researchers found that in 20 LTC facilities across the 
state, an estimated 50% to 75% of LTC residents 
received an antibiotic annually, with a 34.7% 
documented prevalence of penicillin allergy recorded 
in LTC.3
ALK’s Antimicrobial 
stewardship mission
1. 
Raise awareness on the critical impact of 
penicillin allergy labels on infectious disease and 
ever rising healthcare costs.
2. 
Facilitate accurate correction.
We invite all branches of the health system to join 
us and optimize antibiotics use, assuring only those 
with a true penicillin allergy carry the label and are 
empowered to manage their care appropriately.
Attention Ontario Long-Term Care Homes
FREE Penicillin Allergy Re-evaluation Clinics Available This Fall
Unlock first line antibiotics options for your residents – at no cost to your facility
This is a collaborative improvement initiative with trusted clinical partners. 
Limited number of spots are available. Reach out today! 
For more information or to express interest, please contact:
Doris Djantio / Diagnostics Manager & AMS lead, ALK Canada    /    Tel.: 1 437 684 1141  |  Email: doris.djantio@alk.net
The benefits of reclassifying patients as non-allergic are well documented.
21% (p=.008) decrease in 30-day hospital 
readmission rate.5 
In a retrospective study in 2 tertiary care hospitals over 
almost 6 years, patients without a penicillin allergy had 
a 15.1% 30-day readmission rate compared with 19.2% 
for patients with penicillin allergies.5
Nearly 35% (p<.001) decreased risk of infection with 
Clostridioides difficile (C.diff).6
27% (p=.03) lower rate of clinical failure.7 Additionally, 
patients with a reported allergy had a 50% increased risk of 
developing a surgical site infection (p=.04).8
Demonstrated decreases in MRSA and VRE have also been seen in patients 
without penicillin allergies.8,9
1. World Health Organization. WHO AWaRe System for Antimicrobial Stewardship. Who.int. Published 2026. Accessed September 2, 2026. 
https://www.who.int/teams/surveillance-prevention-control-AMR/control-and-response-strategies/AWaRe.
2. Collins C. The low risks and high rewards of penicillin allergy de-labeling: an algorithm to expedite the evaluation. J Pediatr. 2019;212:216-
223. doi:10.1016/j.jpeds.
3. Foong KS, Doron SI, Fowle L, et al. Documented penicillin allergy and beta-lactam antibiotic use in Massachusetts long-term care facilities: 
opportunities for penicillin allergy de-labeling. Antimicrob Steward Healthc Epidemiol. 2024;4(1):e166. doi:10.1017/ash.2024.434 
4. Centers for Disease Control and Prevention. Clinical features of penicillin allergy. cdc.gov. Published August 25, 2025. Accessed 
September 10, 2026. https://www.cdc.gov/antibiotic-use/hcp/clinical-signs/index.html.
5. Huang KH, Cluzet V, Hamilton K, Fadugba O. The impact of reported beta-lactam allergy in hospitalized patients with he-matologic 
malignancies requiring antibiotics. Clin Infect Dis. 2018;67(1):27-33. doi :10.1093/cid/ciy037 
6. Centers for Disease Control and Prevention. Core Elements of hospital antibiotic stewardship. cdc.gov. Published September 15, 2025. 
Accessed September 10, 2026.  https://www.cdc.gov/antibiotic-use/media/pdfs/hospital-core-elements-508.pdf.
7.  Jeffres MN, Narayanan PP, Shuster JE, Schramm GE. Consequences of avoiding _-lactams in patients with _-lactam allergies. J Allergy Clin 
Immunol. 2016;137(4):1148-1153. doi:10.1016/j.jaci.2015.10.026
8. Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES. The impact of a reported penicillin allergy on surgical site infection risk. Clin 
Infect Dis. 2018;66(3):329-336. doi:10.1093/cid/cix794
9. Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort 
study. J Allergy Clin Immunol. 2014;133(3):790-796. doi:10.1016/j.jaci.2013.09.021
By removing the “penicillin allergic”  
label from your nonallergic patients
CHANGE THEIR THERAPY. IMPROVE THEIR OUTCOMES.
Many patients outgrow their penicillin allergy
Lose their sensitivity 
after 10 years4
80%

View this content as a flipbook by clicking here.